Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Betterlife Pharma Inc (OP: BETRF ) 0.1400 +0.0300 (+27.27%) Streaming Delayed Price Updated: 3:53 PM EDT, Aug 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 22,307 Open 0.1110 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1100 Today's Range 0.1110 - 0.1404 52wk Range 0.0309 - 0.1500 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent August 27, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Closing of a Private Placement July 02, 2024 From BetterLife Pharma Inc. Via GlobeNewswire Performance YTD +140.96% +140.96% 1 Month +38.34% +38.34% 3 Month +60.00% +60.00% 6 Month +125.81% +125.81% 1 Year +140.55% +140.55% More News Read More BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria June 26, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Closing of a Private Placement June 14, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001 May 14, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Intent to Complete Private Placement of Units May 03, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Advances BETR-001 IND-enabling Studies May 01, 2024 From BetterLife Pharma Inc. Via GlobeNewswire Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference April 11, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001 April 03, 2024 From BetterLife Pharma Inc. Via GlobeNewswire Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Via Benzinga BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001 January 02, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University March 04, 2024 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Closing of a Private Placement December 18, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Announces Extension of Warrants November 30, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Pharma to Host Investors Update Call on September 18, 2023 September 14, 2023 From BetterLife Pharma Inc. Via GlobeNewswire US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives November 15, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001 September 12, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement September 05, 2023 From BetterLife Pharma Inc. Via GlobeNewswire Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More July 04, 2023 Via Benzinga BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement July 13, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives June 28, 2023 Via Benzinga BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives June 27, 2023 From BetterLife Pharma Inc. Via GlobeNewswire BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada June 22, 2023 From BetterLife Pharma Inc. Via GlobeNewswire Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More June 13, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
